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CASE REPORT 33
A 49-year-old man who received a renal transplant in November 1998 was admitted in 34
December 2005 to the renal transplant unit at Nice University Hospital (France) because of 35 abundant liquid diarrhea and dehydration leading to acute renal failure. His past medical 36 history included chronic renal failure secondary to a polycystic kidney disease. The follow up 37 after kidney transplantation was without any undercurrent problem. At the time of diarrhea, 38 he was given prednisolone (5 mg once daily). Stool samples were performed and send to the 39 laboratory for microbiological investigations. Bacterial and viral investigations were negative. 40
However, several structures consistent with microsporidia spores were found after 41 microscopic examination of both Uvitex and modified trichrome stains. The patient was 42 successfully treated with nitazoxanide (1000 mg twice a day for 60 consecutive days) and the 43 clinical symptoms disappeared. A stool sample performed after nitazoxanide withdrawal was 44 negative for microsporidia. Enterocytozoon bieneusi was identified by a species-specific real-45 time PCR assay as described previously (6). Briefly, DNA was extracted using the QIAamp 46 DNA stool kit (QIAGEN, Courtaboeuf, France) according to the manufacturer's instructions. 47
This E. bieneusi specific real-time PCR assay targeting the small subunit rRNA (SSU rRNA) 48 was applied using a Rotor Gene 3000 platform (Corbett Life Science, Mortlake, Sydney, 49 Australia). Specific detection of E. bieneusi was performed using primers Eb1 50 (CGACAGCCTGTGTGTGAGAATAC) and Eb5 (CAAACGAATGACTTGACCCTGTAA). 51
Detection of the 180-bp product was ensured by use of the specific TaqMan probe EbS2 52 (TGCTTAATTTAACTCAACGCGGGAAAA). To provide further insight into the 53 transmission route (zoonotic or human-to-human transmission) of E. bieneusi in our patient, 54 the internal transcribed spacer ribosomal RNA region (ITS rRNA) region was amplified and 55 sequenced with the primer set MSP3 (GGAATTCACACCGCCCGTCRYTAT) and MSP4B 56 (CCAAGCTTATGCTTAAGTCCAGGGAG (6). PCR products were purified and sequencing 57 on July 8, 2017 by guest http://jcm.asm.org/ Downloaded from 4 was performed using a BigDye terminator sequencing kit on an ABI PrismR 3130 genetic 58 analyzer (Applied Biosystems). Nucleotide sequences were analyzed using Seqscape software 59 (Applied Biosystems). Surprisingly, comparison of the nucleotides sequences of this isolate to 60
GenBank database using the Blast algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed 61 only a weak similarity with previously reported E. bieneusi genotypes. The most similar 62 genotypes (94% homology, 241 bp) were genotypes "Horse 2" and "KB-5" (GenBank 63 accession numbers GQ406054 and JF681179 respectively) that have been recently described 64 in horses and in captive baboons respectively (9, 14). Importantly, a phylogenetic analysis of 65 the ITS rRNA nucleotide sequences of our E. bieneusi isolate (named "MAY1"), together 66 with all ITS rRNA sequences previously reported from humans or human and animal hosts, 67 confirmed the close genetic relationship between our isolate and these highly divergent 68 genotypes (Fig. 1) . Epidemiological investigation by questioning spouse and patient revealed 69 that the week before the symptoms appeared the patient worked in his farm where he breeds 70 horses. Indeed he had to clean a well in which water was contaminated with horse stool. The 71 main hypothesis is that our patient probably gets contaminated during that episode. insights into the understanding of microsporidiosis highlighting a high prevalence of 87 microsporidia in healthy subjects (10, 11). These findings suggest that the real distribution of 88 microsporidiosis in humans is probably underestimated (1). 89
Enterocytozoon bieneusi is probably the species in the genus with the most extensive genetic 90 diversity (13). This genetic diversity of E. bieneusi relies on molecular methods; genetically 91 distinct isolates having similar morphological characteristics (13). Presently, sequencing 92 analysis of the ITS rRNA region is still considered as the gold standard for genotyping and 93 epidemiological studies of E. bieneusi (13, 15) . Until now, more than 90 E. bieneusi 94 genotypes have been reported with new genotypes being regularly described (9, 13). It is now 95 clear, that both host-adapted E. bieneusi genotypes with narrow host ranges and potentially 96 zoonotic genotypes with wide host specificity have been identified (13). Analysis of 97 nucleotide sequences of ITS rRNA provides valuable information about the transmission and 98 pathogenic potential of E. bieneusi because it allows to determine the genotype in human and 99 animal isolates. The most striking finding of our report is the discovery of a new and highly 100 divergent E. bieneusi genotype in a human host. Indeed, near all the genotypes that have been 101
shown to infect humans so far, belong to group 1 (3). To the best of our knowledge, human 102
infections by E. bieneusi isolates that cluster outside the group 1 are exceptional and have 103 been described in a single recent study performed in Central Africa (3). Taken together, E. 104 bieneusi genotype "MAY1" and the one recently reported by Breton et al. in Gabon and 105 Cameroon (genotype "CAF4"), are the only description of a highly divergent E. bieneusi 106 genotype infecting a human host (3). Genotype "MAY1" groups together with the genotype 107 on July 8, 2017 by guest http://jcm.asm.org/ Downloaded from 6 "Horse 2", recently identified in an equid species (14). Interestingly, in our patient, symptoms 108 began after contact with water contaminated with horse stool. Genetic similarity between our 109 new genotype and the one described in an equid species, as well as the close contact with 110 stool horses suggest a zoonotic transmission from horses to our patient. Unfortunately, stools 111 from horses were not available for analysis. 112
In the present case, E. bieneusi infection appeared 7 years after transplantation. This finding is 113 in agreement with previous data from literature with reported cases occurring from 19 days up 114 to 15 years after kidney transplantation (7). At the time of diagnosis, the patient was given 115 immunosuppressive therapy that was maintained while nitazoxanide was introduced. Both 116 albendazole and fumagillin are the main drugs used to treat E. bieneusi infections (7). 117
However, relapse is often observed after albendazole withdrawal and the efficacy of 118 fumagillin is counterbalanced by its adverse effects, fumagillin exhibiting bone marrow 119 toxicity leading to thrombocytopenia and neutropenia (1, 7). Here a complete recovery was 120 obtained with nitazoxanide. This drug is not considered as the first-line therapy but has been 121 already used with success in an HIV-infected patient (2). 122
In conclusion, we report a new and highly divergent genotype of E. bieneusi that is also the 123 first description of an E. bieneusi genotype with close proximity with one recently described 124 in horses (14). Whereas, the real prevalence of microsporidiosis in equid species has been 125 poorly investigated yet, our data suggest that horses could act as potential sources of human 126 microsporidia infections as suggested recently (14). These findings must be considered for the 127 management of immunocompromised patients such as HIV-infected patients and solid-organ 128 transplant recipients. In high-risk patients, giving advices such as avoiding close contact with 129 animals and follow prophylactic measures will probably reduce the burden of this neglected 130 
